Sowell Financial Services’s Anavex Life Sciences AVXL Stock Holding History

Sowell Financial Services’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20	Closed	–	–	697
2021 Q1	$0	Buy	+20	New	+$218	﹤0.01%	3101

Other funds holding AVXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GLA

Great Lakes Advisors Chicago, Illinois $12.1B AUM 29.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sowell Financial Services's AVXL Position: Q2 2021 in Review

Sowell Financial Services sold out of Anavex Life Sciences (AVXL) in Q2 2021, closing a stake of 20 shares.

Sowell Financial Services first reported a position in AVXL in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 127 funds tracked by Wall St. Rank hold AVXL as of Q2 2021.

Sowell Financial Services reported no remaining Anavex Life Sciences position as of Q2 2021 after selling out during the quarter.
Sowell Financial Services sold 20 Anavex Life Sciences shares in Q2 2021.
Sowell Financial Services first reported a position in Anavex Life Sciences in Q1 2021 and held it in 1 quarter.
Sowell Financial Services's Anavex Life Sciences position peaked at $0 in Q1 2021.
127 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.